臨床婦人科産科61巻6号

2007年06月発行

今月の臨床 子宮頸癌の治療─現状と展望

子宮頸癌化学療法の最近の考え方

著者： 本間滋¹ 笹川基¹ 児玉省二¹

所属機関： ¹新潟県立がんセンター新潟病院婦人科

ページ範囲：P.823 - P.831

文献概要

はじめに─子宮頸癌治療における化学療法の位置づけ

　従来，頸癌で化学療法（化療）の対象は，進行例や再発例であり，これらに対しcisplatinが高い臨床的効果があることが確認され^1），これをkey drugとした種々の併用療法が行われるようになった．その後，これらの治療成績を基盤として手術や放射線療法（照射）を行う前に施行する化療（neoadjuvant chemotherapy : NAC）や，化療同時併用放射線療法（concurrent chemoradiation : CCR）が提唱されるようになった．本稿では，これらとともに術後化療（adjuvant chemotherapy）の治療成績を概観し，頸癌治療における化療の意義について考察する．また，頸部腺癌の化療にも言及したい．

参考文献

1) Thigpen JT, Vance R, Puneky L, et al : Chemotherapy as a palliative treatment in carcinoma of the uterine cervix. Semin Oncol 22 : 16-24, 1995

2) Landoni F, Maneo A, Colombo A, et al : Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350 : 535-540, 1997

3) 本間　滋，富田雅俊，笹川　基，他 : 子宮頸癌バルキー型に対するネオアジュバント療法の臨床病理学的検討．日婦腫誌24 : 247，2006

4) Sardi J, Sananes C, Giaroli A, et al : Results of a randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of the cervix. Gynecol Oncol 49 : 156-165, 1993

5) Sardi JE, Giaroli A, Sananes C, et al : Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix : The final results. Gynecol Oncol 67 : 61-69, 1997

6) Sardi JE, Sananes CE, Giaroli AA, et al : Neoadjuvant chemotherapy in cervical carcinoma stage IIB : a randomized controlled trial. Int J Gynecol cancer 8 : 441-450, 1998

7) Chang T-C, Lai CH, Hong JH, et al : Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB andIIA cervical cancer. J Clin Oncol 18 : 1740-1747, 2000

8) Benedetti-Panici P, Greggi S, Colombo A, et al : Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer : Results from the Italian multicenter randomized study. J Clin Oncol 20 : 179-188, 2002

9) Napolitano U, Imperato F, Mossa B, et al : The role of neoadjuvant chemotherapy for squamous cell cervical cancer(Ib-IIIb): a long-term randomized trial. Eur J Gynaec Oncol 24 : 51-59, 2003

10) Buda A, Fossati R, Colombo N, et al : Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma ; The SNAP01(Studio Neo-Adjuvant Portio)Italian Collaborative Study. J Clin Oncol 23 : 4137-4145, 2005

11) Fossati R, Buda A, Rulli E, et al : Randomized trial of neoadjuvant chemotherapy followed by radical surgery in locally advanced squamous cell cervical carcinoma(LASCCC)．Comparison of paclitaxel, cisplatin(TP)，versus paclitaxel, ifosfamide, cisplatin(TIP): The SNAP-02 Italian collaborative study(5026)．J Clin Oncol 23 : 461s, ASCO, 2005

12) Katsumata N, Yoshikawa H, Hirakawa T, et al : Phase IIIrandomized trial of neoadjuvant chemotherapy(NAC)followed by radical hysterectomy(RH)versus RH for bulky I／IIcervical cancer(JCOG 0102)．J Clin Oncol 24 : 259s, ASCO, 2006

13) Park DC, Kim JH, Lew YO, et al : Phase IItrial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer. Gynecol Oncol 92 : 59-63, 2004

14) Souhami L, Gil RA, Allan SE, et al : A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix. J. Clin Oncol 9 : 970-977, 1991

15) Neoadjuvant Chemotherapy for Cervical Cancer Meta-analysis Collaboration : Neoadjuvant Chemotherapy for locally advanced cervical cancer : a systemic review and meta-analysis of individual patient data from 21 randomized trial. Eur J cancer 39 : 2470-2486, 2003

16) Keys HM, Bundy BN, Stehman FB, et al : Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340 : 1154-1161, 1999

17) Rose PG, Bundy BN, Watkins EB, et al : Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 : 1144-1153, 1999

18) Morris M, Eifel PJ, Lu J, et al : Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer. N Engl J Med 340 : 1137-1143, 1999

19) Whitney CW, Sause W, Bundy BN, et al : Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjuvant to radiation therapy in stageIIB-IVA carcinoma of the cervix with nagative para-aortic lymph nodes : A gynecologic oncology group and southwest oncology group study. J Clin Oncol 17 : 1339-1348, 1999

20) Peters WA, Lie PY, Barrett RJ, et al : Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 : 1606-1613, 2000

21) Green A, Kirwan JM, Tierney JF, et al : Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix : a systemic review and meta-analysis. Lnancet 358 : 781-786, 2001

22) http : //www.nccn.org/

23) Pearcey R, Brundage M, Drouin P, et al : PhaseIIItrial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 20 : 966-972, 2002

24) Watanabe Y, Nakai H, Shimaoka M, et al : Feasibility of concurrent cisplatin use during primary and adjuvant chemoradiation therapy : a phase I study in japanese patients with cancer of the uterine cervix. Int J Clin Oncol 11 : 309-313, 2006

25) Chung CK, Nahhas WA, Stryker JA, et al : Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix. Am J Obstet Gynecol 138 : 550-556, 1980

26) Seldis A, Bundy BN, Rotman MZ, et al : A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage Ib carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy : A Gynecologic Oncology Group study. Gynecol Oncol 73 : 177-183, 1999

27) Kinney WK, Alvarez RD, Reid GC, et al : Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis : a matched-control study. Gynecol Oncol 34 : 258-262, 1989

28) Lahousen M, Haas J, Pickel H, et al : Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy : a randomized, prospective, multicenter trial. Gynecol Oncol 73 : 196-201, 1999

29) Tattersall MH, Ramirez C, Coppleson M, et al : A randomized trial of adjuvant chemotherapy after radical hysterectomy in stageIb-IIa cervical cancer patients with pelvic lymph node metastases. Gynecol Oncol 46 : 176-181, 1992

30) Curtin JP, Hoskins WJ, Venkatraman ES, et al : Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy(RH-PLND): a randomized phase IIItrial. Gynecol Oncol 61 : 3-10, 1996

31) Iwasaka T, Kamura T, Yokoyama M, et al : Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma : A comparison with effects of adjuvant radiotherapy. Obstet Gynecol 91 : 977-981, 1998

32) Takeshima N, Umayahara K, Fujiwara K, et al : Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stageIB-IIA cervical cancer. Gynecol Oncol 103 : 618-622, 2006

33) Kavanagh JJ, Gershenson D, Copeland L, et al : Combination chemotherapy for metastatic or recurrent adenocarcinoma of the cervix. J Clin Oncol 5 : 1621-1623, 1987

34) Zanetta G，Lissoni A，Gabriele A, et al : Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma. Gynecol Oncol 64 : 431-435, 1997

35) Umesaki N, Izumi R, Fushiki H, et al : Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin C, etoposide, and cisplatin for advanced or recurrent disease. Gynecol Oncol 75 : 142-144, 1999

36) Curtin JP, Blessing JA, Webster KD, et al : Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix : A Gynecologic Oncology Group Study. J Clin Oncol 19 : 1275-1278, 2001

37) Onishi Y, Yamamoto F, Nakamura T, et al : First line chemotherapy of cervical adenocarcinoma with paclitaxel and carboplatin(5146). J Clin Oncol 23 : 490s ASCO, 2005

38) http://www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid=69375＆version=patient＆protocolsearchid＝3186027

39) Grogan M, Thomas GM, Melamed I, et al : The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 86 : 1528-1536, 1999

40) Strauss HG, Haensgen G, Dunst J, et al : Effects of anaemia correction with epoetin beta in patients with advanced cervical cancer and radiochemotherapy(5121)．J Clin Oncol 23 : 483s, 2005

41) http://www.jcog.jp/study/10_gcsg/0505.htm

42) Rose PG, Blessing JA, Geshenson DM, et al : Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix : A Gynecologic Oncology Group study. J Clin Oncol 17 : 2676-2680, 1999

43) Moore DH, Blessing JA, McQuellon RP, et al : PhaseIIIstudy of cisplatin with or without paclitaxel in stageIVB, recurrent, or persistent squamous cell carcinoma of the cervix : A Gynecologic Oncology Group study. J Clin Oncol 22 : 3113-3119, 2004